Why the study?
The study aimed to investigate the pathogenicity of cardiac ion channel variants previously associated with sudden infant death syndrome.
Do cardiac ion channel variants previously associated with SIDS increase the risk of adverse electrocardiographic traits, syncope, malignant ventricular arrhythmia, or all-cause mortality in population-based cohorts?
Do cardiac ion channel variants previously associated with SIDS increase the risk of adverse electrocardiographic traits, syncope, malignant ventricular arrhythmia, or all-cause mortality in population-based cohorts?
Many genetic variants previously linked to SIDS are not highly penetrant monogenic causes, highlighting the need for frequent reappraisal of genetic variants to prevent misdiagnosis.
Reappraisal of SIDS variants warranted to avoid misdiagnosis; leaves open true genetic contributors in population cohorts.
We aimed to investigate the pathogenicity of cardiac ion channel variants previously associated with SIDS. We reviewed SIDS-associated variants previously reported in databases and the literature in three large population-based cohorts; The ExAC database, the Inter99 study, and the UK Biobank (UKBB). Variants were classified according to the American College of Medical Genetics and Genomics (ACMG) guidelines. Of the 92 SIDS-associated variants, 59 (64%) were present in ExAC, 18 (20%) in Inter99, and 24 (26%) in UKBB. Using the Inter99 cohort, we found no difference in J-point amplitude and QTc-interval between carriers and non-carriers for 14/18 variants. There was no difference in the risk of syncope (P = 0.32), malignant ventricular arrhythmia (P = 0.96), and all-cause mortality (P = 0.59) between carriers and non-carriers. The ACMG guidelines reclassified 75% of all variants as variant-of-uncertain significance, likely benign, and benign. We identified ~2/3 of variants previously associated with SIDS and found no significant associations with electrocardiographic traits, syncope, malignant ventricular arrhythmia, or all-cause mortality. These data indicate that many of these variants are not highly penetrant, monogenic causes of SIDS and underline the importance of frequent reappraisal of genetic variants to avoid future misdiagnosis.
No takes yet. Share an insight, caveat, or question.
Paludan‐Müller et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: